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The Ca2 channels ECaC1 and ECaC2 (TRPV5 and
TRPV6) share several functional properties including
permeation profile and Ca2-dependent inactivation.
However, the kinetics of ECaC2 currents notably differ
from ECaC1 currents. The initial inactivation is much
faster in ECaC2 than in ECaC1, and the kinetic differ-
ences between Ca2 and Ba2 currents are more pro-
nounced for ECaC2 than ECaC1. Here, we identify the
structural determinants for these functional differ-
ences. Chimeric proteins were expressed heterologously
in HEK 293 cells and studied by patch clamp analysis.
Both channels retained their phenotype after exchang-
ing the complete N termini, the C termini, or even both
N and C termini, i.e. ECaC1 with the ECaC2 N or C
terminus still showed the ECaC1 phenotype and vice
versa. The substitution of the intracellular loop between
the transmembrane domains 2 and 3 of ECaC2 with that
of ECaC1 induced a delay of inactivation. Three amino
acid residues (Leu-409, Val-411 and Thr-412) present in
this loop determine the fast inactivation behavior. When
this intracellular loop between the transmembrane
domains 2 and 3 of ECaC1 was exchanged with the TM2-
TM3 loop of ECaC2, the ECaC1 kinetics were analogous
to ECaC2. In conclusion, the TM2-TM3 loop is a critical
determinant of the inactivation in ECaC1 and ECaC2.
Ca2 entry channels play a pivotal role in the regulation of
cell functions such as contraction, secretion, gene expression,
molecular transduction of painful stimuli, osmoregulation, and
transepithelial ion transport. The advent of a novel superfam-
ily of cation channels, the TRP1 family, made it possible to
investigate novel Ca2 entry pathways at the molecular level
in a plethora of cells (1). Most of the channels cloned and
characterized so far from the TRPC subfamily and also the
vanilloid receptors TRPV1, TRPV2, and TRPV4 have only a
moderate selectivity for Ca2 over monovalent cations. Func-
tional characterization of the recently cloned ECaC subfamily
of cation channels (2, 3) revealed a pore structure with a high
selectivity for Ca2 (4). This subfamily is restricted to two
homologous members, namely ECaC1 and ECaC2 (previously
named calcium transporter 1 (CaT1)). These novel Ca2 chan-
nels are implicated in hormonal-regulated active Ca2 trans-
port in epithelia-like kidney and small intestine. Both channels
consist of six transmembrane-spanning domains including a
putative pore-forming region between transmembrane seg-
ments 5 and 6. Genomic analysis shows that ECaC1 and
ECaC2 originate from two genes juxtaposed on human chro-
mosome 7q35 and mouse chromosome 6 (5–7).
We have recently described that ECaC1 and ECaC2 share
several functional properties but also functional differences (8,
9). When heterologously expressed in human embryonic kidney
(HEK) 293 cells, both ECaC members function as highly Ca2-
selective channels that are constitutively open (10–13). Both
channels have the same Eisenman X permeation sequence for
monovalent cations, the same single channel conductance in
the absence of extracellular divalent cations, and display
anomalous mole fraction behavior. Monovalent cation currents
through ECaC are blocked by extracellular Mg2 with an IC50
of 200 M (80 mV) and by extracellular Ca2 with an IC50
between 0.2 and 2 M (80 mV) (10, 13, 14). Recently, it was
demonstrated that also intracellular Mg2 blocks both chan-
nels in a voltage-dependent manner (15). ECaC1 and ECaC2
are inhibited by intracellular Ca2, [Ca2]i, with an IC50 of 200
nM (8, 11). Ruthenium Red is so far the most potent blocker of
both channels; however, ECaC1 is significantly more sensitive
compared with ECaC2 with IC50 values of 120 nM and 9 M,
respectively (8, 16).
Interestingly, there are essential differences between ECaC1
and ECaC2. ECaC1 and ECaC2 show in the presence of extra-
cellular Ca2 a fast initial inactivation at negative membrane
potentials. However, this inactivation is much slower for
ECaC1 (8) in comparison with ECaC2. Also with Ba2 as the
charge carrier, ECaC2 inactivates much slower and more com-
plete than ECaC1 (8). This last feature is the most pronounced
kinetic difference between ECaC1 and ECaC2.
The aim of the present study was to gain insight into the
structural determination of ECaC1 and ECaC2, which are re-
sponsible for the differences in channel kinetics. To this end,
chimeras were constructed from N and C termini and intracel-
lular loops of these channels heterologously expressed in HEK
293 cells and subsequently studied by patch clamp analysis.
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Surprisingly, the N and C termini of both channels are not
responsible for the distinctive kinetic differences between
ECaC1 and ECaC2. However, we identified a region in the
intracellular linker between transmembrane domains 2 and 3
(TM2 and TM3) that determines the initial current decay and
the degree of inactivation.
MATERIALS AND METHODS
Construction of Mammalian Expression Vectors—The entire open
reading frame from mouse ECaC2/CaT1 was cloned as a EcoRI frag-
ment from pSPORT-mECaC2 in the pCINeo/IRES-GFP vector. This
bicistronic expression vector pCINeo/IRES-GFP/ECaC2 was used to
co-express ECaC2 and green fluorescent protein (GFP). The entire open
reading frame from rbECaC1 was cloned as a PvuII-BamHI fragment in
the pCINeo/IRES-GFP vector as described previously (12). To exchange
the ECaC1 N terminus for the ECaC2 N terminus, a unique BspEI site
has been incorporated at amino acid position Ser221-Tyr222 without
affecting the amino acid composition. The N terminus of ECaC1 was
cloned as a NheI-BspEI fragment into the ECaC2 expression vector,
resulting in a chimeric transcript ECaC1-N2, and vice versa for ECaC2,
resulting in ECaC2-N1. A similar strategy was applied to swap the
C-terminal tails by introducing a unique BsiWI site at amino acid
position Arg615-Ser616. The NheI-BsiWI fragments were exchanged, re-
sulting in ECaC1-C2 and ECaC2-C1, respectively. Subsequently, using
the introduced restriction sites, chimeric transcripts were constructed
containing the ECaC1 core protein with the N- and C-terminal tail of
ECaC2 (ECaC1-N2C2) and the ECaC2 core protein with the N- and
C-terminal tail of ECaC1 (ECaC2-N1C1). Finally, the four discriminat-
ing amino acids in the intracellular loop between TM2 and TM3 of
ECaC2 (L409V, V411A, T412S, and F414Y) were mutated according to
the ECaC1 sequence and vice versa by site-directed mutagenesis as
described previously (12). All of the constructed transcripts were veri-
fied by sequence analysis.
Cell Culture and Transfection—HEK 293 were grown in Dulbecco’s
modified Eagle’s medium containing 10% (v/v) human serum, 2 mM
L-glutamine, 2 units/ml penicillin, and 2 mg/ml streptomycin at 37 °C in
a humidity-controlled incubator with 10% (v/v) CO2. HEK 293 cells
were transiently transfected with the pCINeo/IRES-GFP/rbECaC1 or
pCINeo/IRES-GFP/mECaC2 vector using methods as described previ-
ously (12). Transfected cells were visually identified in the patch clamp
setup. GFP was excited at a wavelength between 425 and 475 nm. A
495-nm dichroic mirror was used for GFP, and the emitted light was
passed through a 500-nm long pass filter for GFP. The ECaC1/ECaC2-
expressing cells were identified by their green fluorescence, and GFP-
negative cells from the same batch of cells were used as controls.
Electrophysiology—Electrophysiological methods have been de-
scribed previously in detail (11, 12). Whole-cell currents were measured
with an EPC-9 (sampling rate 0.2 ms, 8-pole Bessel filter 10 kHz, HEKA
Elektronik, Lambrecht, Germany) or an L/M-EPC-7 (List Elektronics,
Darmstadt, Germany) using ruptured patches. Electrode resistances
were between 2 and 5 megohms, and capacitance and access resistance
were monitored continuously. A ramp protocol consisting of linear volt-
age ramps changing from 100 to 100 mV within 400 ms was applied
every 5 s. To study inactivation and the much slower current decay with
Ca2 as the charge carrier in a single protocol, we have applied 3-s
voltage steps to 100 mV from a holding potential of 20 or 70 mV.
Fast inactivation was assessed by the time for 10% decay of the current,
the slower run down by the time constant of a monoexponential fit to
the current during the last 1.5 s of the step. Current densities expressed
per unit membrane capacitance were calculated from the current at
80 mV during the ramp protocols.
Solutions and Experimental Procedures—The standard extracellular
solution (Krebs-Ringer phosphate solution) contained (in mM) 150
NaCl, 6 CsCl, 1 MgCl2, 10 HEPES, and 10 glucose, pH 7.4, adjusted
with CsOH. The concentration of Ca2, Ba2, Sr2, or Mn2 was varied
between 1 and 30 mM as indicated in the text. Nominally free Ca2
concentration was estimated at 10 M. Ca2-free solutions were buff-
ered by 5 mM EGTA at a free [Ca2] below 1 nM as calculated by the
CaBuf program (G. Droogmans, ftp.cc.kuleuven.ac.be/pub/droogmans/
cabuf.zip). To inhibit monovalent cation currents, 150 mM NaCl was
replaced with an equimolar amount of NMDG-Cl. The standard inter-
nal (pipette) solution contained (in mM) 20 CsCl, 100 Cs-aspartate, 1
MgCl2, 10 BAPTA, 4 Na2ATP, and 10 HEPES, pH 7.2, adjusted with
CsOH. Cells were kept in a nominally Ca2-free medium to prevent
Ca2 overload and exposed for maximum of 5 min to a Krebs-Ringer
phosphate solution containing 1.5 mM Ca2 before sealing the patch
pipette to the cell. All of the experiments were performed at room
temperature (20–22 °C).
Statistical Analysis—Data are expressed as the mean  S.E. Overall
statistical significance was determined by analysis of variance
(ANOVA). In the case of significance (p  0.01), individual groups were
compared by Student’s t test. Experimental data were fitted to a mo-
noexponential function using the fitting routine of the WinASCD pro-
gram (G. Droogmans). Dose-inhibition data were fitted to a dose re-
sponse function using Origin software version 6.0 (Microcal Software,
Northhampton, MA).
RESULTS
Kinetic Differences between ECaC1 and ECaC2 Currents—
Inactivation of ECaC1 and ECaC2 currents with Ca2 or Ba2
as the charge carrier at negative potentials revealed the most
striking functional difference between both channels. Fig. 1, A
and B, shows representative current traces during a voltage
step to 100 mV in solutions with all monovalent cations
substituted by NMDG. Therefore, inward currents were car-
FIG. 1. Inactivation of ECaC1 and
ECaC2 currents in 30 mM [Ca2]e. A
and B, currents through ECaC1 and
ECaC2 in response to a voltage step to
100 mV (VH  70 mV) in the presence
of 30 mM [Ca2]e. All of the other cations
are substituted by 150 mM NMDG. Cells
were loaded with 10 mM BAPTA. The in-
sets show currents normalized to the
peak. C, pooled data comparing the time
for 10% inactivation (t10%) during a volt-
age step as in A and B between ECaC1
and ECaC2. The number of cells is indi-
cated in parentheses. D, pooled data com-
paring the time constants of the monoex-
ponential fit of the last 1.5 s of the voltage
step as in A and B (1.5s) between ECaC1
and ECaC2. E, the time to 10% decay for
Ba2 and Ca2 currents through ECaC1.
F, same as in E but through ECaC2.
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ried by either Ca2 or Ba2. The initial rapid phase of inacti-
vation of ECaC2 assessed from the time to 10% current decay
was significantly faster than that of ECaC1 (Fig. 1C). The late
decay of the current assessed from the time constant of a
monoexponential fit to the last 1.5 s of the voltage step to 100
mV was not significantly different between the two channels
(Fig. 1D). If Ba2 was used as the charge carrier, the time to
10% inactivation for ECaC1 was only modestly prolonged com-
pared with the Ca2 current (Fig. 1E). However, for ECaC2,
these differences were significantly more pronounced (Fig. 1F)
as is obvious from Fig. 1, insets in A and B, which shows the
currents normalized to the peak values with Ca2 as the charge
carrier. Time to 10% inactivation was 112  14 ms (n  41) for
Ca2 currents through ECaC1 and 169  21 ms (n  15) for
Ba2 currents. The same measurements for ECaC2 resulted in
45  5 ms (n  24) for Ca2 and 830  95 ms (n  17) for Ba2.
The kinetic difference between both channels can be more
impressively described by the ratio between these times,
t10%,Ca/t10%,Ba, which was 0.66 for ECaC1 but 0.05 for ECaC2.
The ratio of the Ca2 and Ba2 current densities was also
significantly different between ECaC1 (0.69  0.05 (n  12))
and ECaC2 (0.39  0.03 (n  15)).
Exchange of the N and C Termini between ECaC1 and
ECaC2—The N-terminal tails of ECaC1 (N1) and ECaC2 (N2),
which share 81.3% homology, were exchanged to identify the
structural determinants for the functional differences between
these two channels. Fig. 2 shows typical traces of the inactiva-
tion of Ca2 and Ba2 currents for both chimeras. For ECaC1-
N2, the chimera in which the ECaC1 N terminus was substi-
tuted by that of ECaC2, the time for 10% inactivation of the
Ca2 current remained long (210  55 ms, n  6) as is typical
for ECaC1 (Fig. 2A) (see Fig. 4 for a summary of the analysis).
In contrast, the time for 10% inactivation of the Ba2 current
was prolonged compared with that of wild-type ECaC1 (313 
79 ms, n  6) but was still much shorter than that of ECaC2.
The kinetic coefficient, t10%,Ca/t10%,Ba, was nearly identical to
ECaC1. The ratio IBa/ICa was 1.03  0.12 (n  6, same cells).
This ratio reflects the ECaC1 more than the ECaC2 phenotype.
However, Ba2 currents through this chimera were signifi-
cantly larger compared with ECaC1.
The phenotype of ECaC2-N1 obtained by exchanging the N
terminus of ECaC2 for that of ECaC1 was very similar to that
of wild-type ECaC2. However, the decay of the Ba2 current is
significantly slower compared with the Ca2 current (Fig. 2B).
The time to 10% decay of the Ca2 current was not significantly
altered compared with wild-type ECaC2 (69  11, n  9),
whereas the Ba2 current is again prolonged (529  136, n 
9). The ratio IBa/ICa was 0.45  0.08 (n  7, values only from
the same cells) and not significantly different from wild-type
ECaC2.
Because the exchange of the N-terminal tails did not affect
the inactivation kinetics of the ECaC channel, we exchanged
their C-terminal tails, which display a homology of 61%. It is
obvious from the current traces in Fig. 2C that the time course
of inactivation of the ECaC1-C2 chimera in which the ECaC1 C
terminus is substituted by the complete C-terminal tail of
ECaC2 is not significantly different from wild-type ECaC1
(t10%,Ca  230  49, n  9, and t10%,Ba  379  66, n  10).
However, the ratio IBa/ICa was significantly increased to 1.15 
0.17 (n  8) compared with wild-type ECaC1. Similarly, the
kinetic properties of ECaC2-C1 obtained by replacing the
ECaC2 C terminus with the C-terminal tail of ECaC1 were
identical to those of wild-type ECaC2 (Fig. 2D). The time to
10% inactivation was 35  7 ms (n  11) for Ca2 currents and
918  112 ms (n  12) for Ba2 currents. Similarly, the IBa/ICa
ratios were not significantly different, i.e. 0.43  0.04 (n  10)
for ECaC2-C1 compared with 0.49 for the wild type.
In the next experiment, the effects of exchanging both N and
C termini were studied. Fig. 3 summarizes the obtained re-
sults. The time to 10% inactivation of both Ca2 and Ba2
currents was significantly prolonged if ECaC1 contained both
the N and the C termini of ECaC2 (t10%,Ca  512  167 ms, n 
6, and t10%,Ba  825  182 ms, n  4). However, as for all
chimeras, the differences between the kinetics of the Ca2 and
Ba2 currents were small (t10%,Ca/t10%,Ba  0.62), and the fast
initial phase of inactivation was lacking (Fig. 3, A and B). The
IBa/ICa ratio of 1.06  0.09 (n  4, same cells) was increased but
matched again the ECaC1 rather than the ECaC2 phenotypes.
As for the other chimeras, the fast component of inactivation
and the large differences in kinetics of the Ca2 and Ba2
currents were conserved whether the N- and the C-terminal
tail of ECaC2 was exchanged with those of ECaC1 (t10%,Ca 
94  18 ms, n  5, and t10%,Ca/t10%,Ba  678  87 ms, n  5)
(Fig. 3, C and D). The ratio between the Ba2 and Ca2 cur-
FIG. 2. Changes in current pattern
during hyperpolarizing voltage steps
in ECaC1 and ECaC2 chimeras in
which N and C termini were ex-
changed. A, currents through the
ECaC1-N2 chimera in which the N termi-
nus of ECaC1 was exchanged with the N
terminus of ECaC2. In all of the figures,
open and filled bars represent structural
components of ECaC1 and ECaC2, re-
spectively. Current traces in response to a
voltage step to 100 mV (VH  70 mV)
in the presence of 30 mM [Ca2]e and all of
the monovalent cations substituted by
150 mM NMDG. Cells were loaded with 10
mM BAPTA. B, currents through the
ECaC2-N1 chimera in which the N termi-
nus of ECaC2 was exchanged with the N
terminus of ECaC1. Same protocol as in A
was used. C, currents through the
ECaC1-C2 (C terminus of ECaC1 ex-
changed with the C terminus of ECaC2).
D, currents through the ECaC2-C1 (C ter-
minus of ECaC2 exchanged with the C
terminus of ECaC1).
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rents, IBa/ICa, was 0.56  0.08 (n  5, same cells) and similar
to the ECaC2 phenotype. Both chimeras exhibit similar expres-
sion levels, i.e. the density of the monovalent cation current in
the absence of divalent cations at 80 mV was 692  46
pA/pF (n  8) for ECaC1-N2C2 and 827  114 pA/pF (n  6)
for ECaC2-N1C1.
Fig. 4 summarizes the data concerning the initial fast inacti-
vation. The time to 10% decay of the Ca2 current for all ECaC1
chimeras ranged between 100 and 500 ms. For ECaC2 and its
chimeric proteins, the 10% current decay occurred in 100 ms
(Fig. 4A). The initial decay of Ba2 currents was slower than that
of the Ca2 currents. The ratio of the time to 10% decay of the
Ca2 current and the Ba2 current (t10%,Ca/t10%,Ba) ranged be-
tween 0.5 and 0.9 for ECaC1 and its corresponding chimeras and
was  0.25 for ECaC2 and the corresponding chimeras.
The fraction of open channels at the end of a 3-s hyperpolar-
izing step expressed as the ratio of the current densities at the
end of the pulse and the peak current was similar for all of the
chimeras and for both charge carriers. This ratio, which scat-
ters substantially and also depends on the size of the current
(8), was 15% at the end of the pulse (Fig. 5), suggesting that
the swapping of the N and C termini did not significantly affect
the inactivation behavior. Therefore, the exchange of either or
both N and C termini between ECaC1 and ECaC2 did not
change severely the inactivation kinetics of the wild-type chan-
nel, indicating that other domains or even the core structure
may determine the discriminating inactivation kinetics of
ECaC1 and ECaC2.
Substitution of the Intracellular Linker Domain between the
Transmembrane Regions TM2 and TM3—Because the ex-
change of the cytoplasmic N- and C-terminal tails did not affect
the phenotype of the channel kinetics, we replaced the intra-
cellular linker between TM2 and TM3 (ICL1ECac1 for the
ECaC1 linker and ICL1ECaC2 for the ECaC2 linker). Intrigu-
FIG. 4. Summary of the fast decay
by swapping of the N and C termini
between ECaC1 and ECaC2. A, the
time to 10% inactivation with 30 mM Ca2
as the charge carrier (data for ECaC1
shown on top and ECaC2 on bottom). All
data are from between 4 and 41 cells. B,
ratio of the time to 10% inactivation for
Ca2 and Ba2 (t10%Ca/t10%Ba).
FIG. 3. Inactivation properties of a
chimera in which both N and C ter-
mini were exchanged for ECaC1 and
ECaC2. A, currents through the ECaC1-
N2C2 chimera in which both the N termi-
nus and C terminus of ECaC1 were ex-
changed by the ones of ECaC2. B, pooled
data comparing the time for 10% inacti-
vation (t10%) for wild-type ECaC1 and
ECaC1-N2C2. C, currents through the
ECaC2-N1C1 chimera in which the N and
C termini of ECaC2 were exchanged with
the tails of ECaC1. Same voltage protocol
as in panel A was used. D, pooled data
comparing the time for 10% inactivation
(t10%) for wild-type ECaC2 and ECaC2-
N1C1. Data are from 6 to 8 cells.
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ingly, the inactivation properties of the ECaC2 channel were
drastically affected by substitution of its first intracellular loop
with that of ECaC1 (Fig. 6). Panel A shows the main kinetic
features of ECaC2 including fast initial inactivation, delayed
inactivation with Ba2 as the charge carrier, dramatic differ-
ences in the time to 10% inactivation between Ca2 and Ba2
currents, and a smaller current density of Ba2 compared with
the Ca2 currents. The inactivation of both Ca2 and Ba2
currents was delayed in the loop1 ECaC2/ICL1ECac1 chimera
(Fig. 6, B and C). In addition, the fraction of channels inacti-
vated at the end of the 3-s pulse was much less in ECaC2
compared with wild-type ECaC2 (Fig. 6D), indicating a defect
of ECaC2 inactivation in this chimeric protein. The times to
10% inactivation were 929  150 ms (n  11) for Ca2 and
2878  40 ms (n  8) for Ba2. In this analysis, the t10% of the
current that did not inactivate at all was set at 3 s, which is
identical to the step duration. Thus, these quantitative data
even represent an underestimation. The ratio between Ba2
and Ca2 current, IBa/ICa, was 0.36  0.03 (n  9, same cells),
reflecting the ECaC2 phenotype. Similar results were obtained
with 10 mM Ba2 and Ca2 as the charge carrier (data not
shown, n  12). Whether the opposite chimera, the first intra-
cellular loop of ECaC2, ICL1ECaC2, was introduced in ECaC1
(chimera ECaC1/ICL1ECaC2), no dramatic changes were ob-
served, although it displayed some features of the ECaC2 phe-
notype. Fig. 6E showed the kinetic behavior of this chimera. In
contrast to wild-type ECaC1, the initial inactivation was sig-
nificantly accelerated, e.g. from 112  14 ms (n  41) to 15 
3 ms (n  9) for ECaC1/ICL1ECaC2 (Fig. 6F). This value is much
closer to ECaC2 (45  5 ms, n  24). Also in contrast to ECaC1,
which does not strongly differentiate during the initial phase of
inactivation between Ca2 and Ba2, the ECaC1/ICL1ECaC2
chimera has now a strikingly delayed time to 10% inactivation
for Ba2 as compared with Ca2 (130  25 ms, n  8). The ratio
between both times, t10%,Ca/t10%,Ba was 0.18  0.05, which was
closer to the ECaC2 than to the ECaC1 phenotype. In addition,
the ratio between the peak Ba2 and Ca2 currents, IBa/ICa was
0.47  0.06, which is intermediate between the ECaC1 and
ECaC2 phenotypes. The fraction of channels, which are open at
the end of the 3-s step, was dramatically changed in the
ECaC2/ICL1ECaC1 chimera. However, the same change from
ECaC2 to ECaC1 resulted again in the ECaC2 phenotype. The
inactivation of the Ca2 currents was nearly complete in both
ECaC1 and ECaC2 (0.05  0.02, n  12, and 0.06  0.03, n 
10). The inactivation of Ba2 currents through ECaC2 was
diminished as compared with ECaC1 (0.13  0.03, n  10, for
ECaC2 and 0.07  0.01, n  10, for ECaC1). Similar data were
measured for the ECaC1/ICL1ECaC2 chimera, e.g. 0.11  0.03
(n  8) for Ba2 and 0.030  0.004 (n  9) for Ca2. Thus, the
kinetic behavior of this chimera further supports the essential
role of the intracellular linker between TM2 and TM3 as a
critical determinant of the kinetic behavior of the ECaC
channels.
To identify the amino acid residues, which might be crucial
for this dramatic change in phenotype, we have exchanged the
divergent residues in TM2-TM3 of ECaC2 by the corresponding
amino acids from the TM2-TM3 loop in ECaC1, i.e. L409V,
V411A, T412S, and F414Y (Fig. 7). The effects of swapping the
entire TM2-TM3 loop are depicted at the top rows of the four
panels. The mutations at positions 409, 411, and 412 cause a
significant delay of the initial decay of the Ca2 current and a
more pronounced prolongation of the inactivation of the Ba2
current. These mutations resulted in a highly significant de-
crease of inactivation assessed from the ratio between the
current at the end of the pulse and the peak current. An
exchange of Phe-414 into a tyrosine had no effect. These data
indicate that the N-terminal part of this intracellular linker is
critically involved in controlling ECaC2 inactivation.
DISCUSSION
This study demonstrates that the intracellular loop between
TM2 and TM3, particularly Leu-409, Val-411, and Thr-412,
determines the initial rapid inactivation kinetics of ECaC1 and
ECaC2, whereas the cytoplasmic N- and C-terminal tails do not
contribute significantly.
Voltage-operated Ca2 channels contain in the N and C
termini major determinants of the inactivation process (17–23).
Likewise, the N and C termini of the ECaCs contain many
putative regulatory domains including protein kinase C and
calmodulin-activating kinase phosphorylation sites, postsynap-
tic density protein, Disc large tumor suppressor, Zonula occlu-
dens protein motifs, and ankyrin repeats (2). It has been re-
cently shown that the human isoform CaT-L is highly
homologous to ECaC2 and inactivates in a Ca2-dependent
FIG. 5. Summary of the inactivation
properties of the chimeras. The ratio
of the current at the end of the 3-s step
from 70 or 20 to 100 mV and the
peak current are plotted against the re-
spective chimera. The charge carrier is 30
mM Ca2 (solid bar) or 30 mM Ba2
(striped bar). Note that for all chimeras,
the fraction of open channels is always
25%, indicating the substantial inacti-
vation for all constructs.
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manner via a multiphasic process. This process is character-
ized by a rapid Ca2-dependent phase followed by a Ca2-CaM-
dependent phase (24). The calmodulin-dependent inactivation
can be counteracted by the phosphorylation of a protein kinase
C site in the C terminus (24). However, the proposed calmod-
ulin binding site in human CaT-L is not conserved, and also the
protein kinase C site, which counteracts Ca2-dependent inac-
tivation in CaT-L, is not present in ECaC1. Therefore, the
swapping of the C termini of both ECaC channels could further
evaluate such a mechanism. The cytoplasmic tails of ECaC1
and ECaC2 were exchanged, and the chimeric proteins ex-
pressed in HEK 293 cells were studied by patch clamp analysis.
Surprisingly, the swapping of the entire intracellular N and C
termini did not basically alter the inactivation kinetics of
ECaC1 and ECaC2. Of note, Suzuki et al. (25) demonstrated
that in the C terminus, the Q579H mutation in ECaC1 and the
corresponding H587Q mutation in ECaC2 play a role in the
inactivation process. However, in this latter study, the inacti-
vation process was not studied in detail, and the information on
the fast and subsequent slower inactivation process is lacking.
FIG. 6. Inactivation properties of chimeras in which the intracellular loop between the transmembrane domains 2 and 3 in ECaC2
was replaced by the corresponding loop of ECaC1. A, currents through the ECaC2 wild type. Conditions are the same as in Fig. 1. B, currents
through the chimera ECaC2/ICL1ECaC1 in which the intracellular loop between transmembrane domains 2 and 3 of ECaC2 was exchanged by the
respective intracellular loop of ECaC1 (ICL1ECaC1). C, summary of the time to 10% decay (t10%) for wild-type ECaC2 and the ECaC2/ICL1ECaC1
chimera. D, pooled data comparing the fraction of inactivated channels after 3-s hyperpolarization to 100 mV from a holding potential of 70 mV.
Note that the degree of inactivation was dramatically reduced for the chimeras for both Ca2 and Ba2 as the charge carrier. E, currents through
the chimera ECaC1/ICL1ECaC2 in which the intracellular loop between transmembrane domains TM2 and TM3 of ECaC1 was exchanged by the
respective intracellular loop of ECaC2. F, summary of the time to 10% decay (t10%) for wild-type ECaC1 and the ECaC1/ICL1ECaC2 chimera. Note
the fast initial inactivation and the large difference between Ca2 and Ba2 for the chimera but not for wild-type ECaC1.
FIG. 7. Inactivation properties of
mutations in the TM2-TM3 loop of
ECaC2. A, pooled data for the fast decay
of the current during the hyperpolarizing
step to 100 mV for Ca2 and Ba2 as the
charge carrier. The tested mutants are
indicated at the left. B, degree of inactiva-
tion measured as the fraction of open
channels at the end of the 3-s step (I3s/
Ipeak). Note the dramatic defect of inacti-
vation for the mutants at positions 409,
411, and 412 but not 414.
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However, this study indicates that the cytoplasmic tails of
ECaC1 and ECaC2 are not responsible for the difference in
inactivation behavior of both channels.
A detailed comparison of the intracellular loops of ECaC1
and ECaC2 demonstrated that the domain between TM3 and
TM4 is identical, whereas the loop between TM2 and TM3
contains four conserved amino acid differences (26). Chimeras
were constructed in which the discriminating TM2-TM3 loop
was exchanged. A subsequent electrophysiological analysis
demonstrated that the characteristic fast inactivation of the
ECaC2 current was absent in the ECaC2/ICL11 chimera and
therefore mimicked the inactivation kinetics of ECaC1. The
point mutations of the discriminating four amino acids re-
vealed that Leu-409, Thr-412, and to a lesser extent Val-411
but not Phe-414 convey the molecular determinants of the fast
inactivation process occurring in ECaC2. Importantly, this ob-
servation is further substantiated by the finding that transfer-
ring the ECaC2 TM2-TM3 linker to ECaC1 resulted in a shift
of the kinetic phenotype of ECaC1 toward ECaC2. Especially,
the inactivation of ECaC1 is accelerated, and the kinetic dis-
crimination between Ca2 and Ba2 is accentuated. Interest-
ingly, this critical motif is not present in other channel proteins
and does not resemble the classical calmodulin-binding
domain.
Interestingly, we have identified a short stretch of amino
acids that is involved in the fast inactivation of ECaC2 when
Ca2 is the charge carrier. This situation is similar to Ca2-
dependent inactivation of L-type 1C Ca2 channels (27–29).
In the study by Pitt et al. (29), it has been shown that Ca2-
dependent inactivation requires the tethering of the Ca2 sen-
sor calmodulin to an effector region, which is supported by
other stretches of amino acids. These stretches contain puta-
tive calmodulin-binding sequences. It is intriguing to speculate
a similar role for the linker identified here. This linker is a
critical motif, which is not present in other channel proteins. It
does not resemble the classical calmodulin-binding domain but
might contain a new calmodulin binding sequence or another
inactivation mechanism, including interaction with another
Ca2 sensor, could be operative.
Another distinctive feature of both Ca2 channels is that the
ratio of Ba2 and Ca2 currents, IBa/ICa, through both channels
is different (8), e.g. the ratio is significantly larger for ECaC1
than for ECaC2. This ratio may result from a smaller single
channel conductance for Ba2 than for Ca2 for ECaC2 in
comparison with ECaC1 or a decreased open probability of
ECaC2 if Ba2 is the charge carrier. This feature is again
conserved for all chimeras including the loop chimera. The
current ratio for all chimeras with the ECaC1 core was in a
range between 0.69 and 1.15, whereas for all chimeras with the
ECaC2 core, the ratio scattered between 0.39 and 0.56. This
feature is also not changed by the translocation of the first
intracellular linker and the mutations within this linker. This
conserved behavior indicates that the mechanism by which
both channels differentially discriminate between Ba2 and
Ca2 is not located in the swapped domains and rather may be
related to other region of the channels including the pore.
In conclusion, the present observations suggest that the res-
idues Leu-409, Val-411, and Thr-412 present in the intracellu-
lar loop between TM2 and TM3 determine the fast inactivation
of ECaC2. The ECaC2 residues may form part of an inactiva-
tion gate receptor region, and the definition of the state-de-
pendent events may elucidate the molecular interactions im-
portant for gating transitions among closed, open, and
inactivated states of the epithelial Ca2 channel.
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29. Pitt, G. S., Zühlke, R. D., Hudmon, A., Schulman, H., Reuter, H., and Tsien,
R. W. (2001) J. Biol. Chem. 276, 30794–30802
Structure Function Analysis of ECaC1 and ECaC230858
